- Equipment
- Software
- Consumables
Live Cell Imaging Market size was valued at USD 2.8 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 11.6% from 2024 to 2030 to reach USD 6.03 billion in 2030. The live cell imaging market refers to the industry involved in technologies and equipment that observe living cells in real time using microscopy and related imaging techniques. This field is crucial for studying cellular dynamics, processes, and interactions within their natural environments, without disrupting their biological activities. The live cell imaging market serves a broad spectrum of applications across various fields including cell biology, neuroscience, microbiology, cancer research, drug discovery, regenerative medicine, and developmental biology, catering to diverse research needs in each domain.
The expansion of the live cell imaging market is driven by the increased use of high-content screening methods in drug discovery, the growing incidence of chronic diseases necessitating faster and more accurate diagnostic capabilities, and governmental support for research focused on cell-based approaches. Furthermore, advancements in product innovation are also fueling market expansion. For instance, in June 2021, Leica Microsystems introduced the Leica Nano workflow, a novel solution for live-cell correlative light and electron microscopy (CLEM). This innovation aims to enhance experimental success rates, improve reproducibility, and streamline the integration of light and electron microscopy. Similarly, in January 2021, Zeiss Group launched the ZEISS Visioner 1, a cutting-edge digital microscope designed for live-cell imaging. Featuring the Micro-mirror Array Lens System (MALS), this microscope simplifies real-time focusing and aims to increase throughput. These initiatives are anticipated to drive market growth throughout the forecast period. However, factors such as the high cost of high-content screening systems and the shortage of skilled professionals may hinder the market's growth.
Live Cell Imaging Market Key Developments:
- In June 2023, Nanolive launched the 3D Cell Explorer 96focus, an innovative platform that brings unlimited high content analysis to label-free live cell imaging without the need for labelling. With the aid of AI-powered digital assays and an automated workflow, the 3D Cell Explorer 96focus streamlines the imaging process, offering researchers a cost-effective and reliable means of conducting cell imaging experiments.
- In February 2023, Nikon Corporation launched the Nikon Spatial Array Confocal (NSPARC) detector for AX systems. This detector enables high-resolution imaging of live tissue with minimal phototoxicity.
Live Cell Imaging Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
11.6%
Largest Market
North America
Fastest Growing Market
Asia Pacific
Live Cell Imaging Market Dynamics
The increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders has underscored the need for a deeper understanding of cellular processes. Live cell imaging provides a unique approach to observing the dynamic behaviour of living cells in real-time. Researchers utilize this technology to investigate the mechanisms underlying diseases, screen potential drug candidates, and evaluate treatment responses. In the era of personalized medicine, live cell imaging allows for the study of patient-specific cells, offering insights into disease progression and personalized therapeutic approaches. Furthermore, biological research has made significant strides, with scientists continually uncovering new insights into cellular functions and interactions. Live cell imaging plays a crucial role in these advancements by enabling researchers to visualize dynamic cellular processes and monitor cellular behaviours over time. This capability is instrumental in studying processes such as cell division, migration, and signalling pathways, leading to breakthroughs across diverse fields including neuroscience, immunology, and regenerative medicine. As scientists strive to unravel the complexities of cellular life, live cell imaging remains an essential tool, driving its increasing demand within the market.
North-America Got Significant Share of
Live Cell Imaging Market Regional Analysis
Based on regions the market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. In 2023, North America accounted for the largest revenue share in the live cell imaging market. The region has experienced consistent growth, largely fueled by extensive research and development initiatives. Countries like the United States and Canada host numerous leading pharmaceutical and biotechnology firms, driving significant demand for live cell imaging technologies in drug discovery and development efforts. The Asia-Pacific region is expected to witness the most rapid growth in the live cell imaging market. This expansion is driven by burgeoning life sciences research, rising investments in healthcare infrastructure, and growing recognition of the technology's capabilities. The Asia-Pacific region is increasingly recognized as a significant participant in the global live cell imaging market, emphasizing its efforts to meet regional healthcare demands and advance scientific research.
Latin America
Europe
Asia Pacific
Middle East
North America
Live Cell Imaging Market Segmentation
By Product
By Application
- Cell Biology
- Developmental Biology
- Stem Cell
- Drug Discovery
By Technology
- Fluorescence Resonance Energy Transfer (FRET)
- Fluorescence Recovery after Photobleaching (FRAP)
- High Content Screening (HCS)
- Others
Frequently Asked Questions
The global live cell imaging market size was valued at USD 2.8 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 11.6% from 2024 to 2030 to reach USD 6.03 billion in 2030.
The leading players in the market of global live cell imaging are Danaher Life Sciences, Nikon Corporation, Olympus Life Sciences, GE HealthCare, Bruker, Thermo Fischer Scientific, Sartorius, Etaluma, Agilent BioTek, PerkinElmer, Zeiss, NanoEntek, Leica Microsystems, and Revvity
North America dominated the market share because of extensive research and development initiatives. Countries like the United States and Canada host numerous leading pharmaceutical and biotechnology firms, driving significant demand for live cell imaging technologies in drug discovery and development efforts.
The expansion of the live cell imaging market is driven by the increased use of high-content screening methods in drug discovery, the growing incidence of chronic diseases necessitating faster and more accurate diagnostic capabilities, and governmental support for research focused on cell-based approaches.
Key Features of the Report
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030).
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies.
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market.
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market.
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenarios.
| 1.Executive Summary |
| 2.Global Live Cell Imaging Market Introduction |
| 2.1.Global Live Cell Imaging Market - Taxonomy |
| 2.2.Global Live Cell Imaging Market - Definitions |
| 2.2.1.Product |
| 2.2.2.Application |
| 2.2.3.Region |
| 3.Global Live Cell Imaging Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Live Cell Imaging Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Live Cell Imaging Market By Product, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Equipment |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Software |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Consumables |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6.Global Live Cell Imaging Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Cell Biology |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Developmental Biology |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Stem Cell |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Drug Discovery |
| 6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7.Global Live Cell Imaging Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia Pacific (APAC) |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Middle East and Africa (MEA) |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Latin America |
| 7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8.North America Live Cell Imaging Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1.Equipment |
| 8.1.2.Software |
| 8.1.3.Consumables |
| 8.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.2.1.Cell Biology |
| 8.2.2.Developmental Biology |
| 8.2.3.Stem Cell |
| 8.2.4.Drug Discovery |
| 8.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.3.1.United States of America (USA) |
| 8.3.2.Canada |
| 9.Europe Live Cell Imaging Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Equipment |
| 9.1.2.Software |
| 9.1.3.Consumables |
| 9.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Cell Biology |
| 9.2.2.Developmental Biology |
| 9.2.3.Stem Cell |
| 9.2.4.Drug Discovery |
| 9.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Germany |
| 9.3.2.France |
| 9.3.3.Italy |
| 9.3.4.United Kingdom (UK) |
| 9.3.5.Spain |
| 10.Asia Pacific (APAC) Live Cell Imaging Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Equipment |
| 10.1.2.Software |
| 10.1.3.Consumables |
| 10.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Cell Biology |
| 10.2.2.Developmental Biology |
| 10.2.3.Stem Cell |
| 10.2.4.Drug Discovery |
| 10.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.China |
| 10.3.2.India |
| 10.3.3.Australia and New Zealand (ANZ) |
| 10.3.4.Japan |
| 10.3.5.Rest of APAC |
| 11.Middle East and Africa (MEA) Live Cell Imaging Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Equipment |
| 11.1.2.Software |
| 11.1.3.Consumables |
| 11.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Cell Biology |
| 11.2.2.Developmental Biology |
| 11.2.3.Stem Cell |
| 11.2.4.Drug Discovery |
| 11.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.GCC Countries |
| 11.3.2.South Africa |
| 11.3.3.Rest of MEA |
| 12.Latin America Live Cell Imaging Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Equipment |
| 12.1.2.Software |
| 12.1.3.Consumables |
| 12.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Cell Biology |
| 12.2.2.Developmental Biology |
| 12.2.3.Stem Cell |
| 12.2.4.Drug Discovery |
| 12.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Brazil |
| 12.3.2.Mexico |
| 12.3.3.Rest of LA |
| 13. Competition Landscape |
| 13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 13.2.1.Danaher Life Sciences |
| 13.2.2.Nikon Corporation |
| 13.2.3.Olympus Life Sciences |
| 13.2.4.GE HealthCare |
| 13.2.5.Bruker |
| 13.2.6.Thermo Fischer Scientific |
| 13.2.7.Sartorius |
| 13.2.8.Etaluma |
| 13.2.9.Agilent BioTek |
| 13.2.10.PerkinElmer |
| 13.2.11.Zeiss |
| 13.2.12.NanoEntek |
| 13.2.13.Leica Microsystems |
| 13.2.14.Revvity |
| 14. Research Methodology |
| 15. Appendix and Abbreviations |
- Danaher Life Sciences
- Nikon Corporation
- Olympus Life Sciences
- GE HealthCare
- Bruker
- Thermo Fischer Scientific
- Sartorius
- Etaluma
- Agilent BioTek
- PerkinElmer
- Zeiss
- NanoEntek
- Leica Microsystems
- Revvity